Celiac Disease Market Analysis, Market Size, Epidemiology, Leading Companies and Competitive Analysis by DelveInsight

July 14 00:06 2020
Celiac Disease Market Analysis, Market Size, Epidemiology, Leading Companies and Competitive Analysis by DelveInsight

“Celiac Disease (CD) Market Insights, Epidemiology, and Market Forecast-2030”.

Delveinsight has launched a new report on Celiac Disease (CD) Market Insights, Epidemiology, and Market Forecast-2030″.

 

 

DelveInsight’s Celiac Disease Market Insights, Epidemiology, and Market Forecast-2030 report delivers an in-depth understanding of the Celiac Disease (CD) , historical and forecasted epidemiology as well as the Celiac Disease (CD) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

 

Some of the Facts:

  1. Celiac Disease is estimated to affect 1 in 100 people worldwide.
  2. Celiac disease was found to be more common in women than in men and equally prevalent in children and adults.
  3. An estimated 1 in 133 Americans have celiac disease. Celiac disease can affect men and women of all ages and races.
  4. 5-22% of people with celiac disease have an immediate family member (first degree relative) who also has celiac disease.

 

Key benefits

1. Celiac Disease market report covers a descriptive overview and comprehensive insight of the Celiac Disease epidemiology and Celiac Disease market in the 7 MM (United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
2. Celiac Disease market report provides insights on the current and emerging therapies.
3. Celiac Disease market report provides a global historical and forecasted market covering drug outreach in 7MM.
4. Celiac Disease market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Celiac Disease market.

Request for Free Sample Report: https://www.delveinsight.com/sample-request/celiac-disease-cd-market

 

“5-22% of people with celiac disease have an immediate family member, who has celiac disease.”

 

Celiac disease also known as coeliac disease/Non-tropical sprue or gluten sensitive enteropathy, is defined as a chronic, multiple-organ small intestinal immune-mediated enteropathy precipitated by exposure to dietary gluten in genetically predisposed people. It is a serious autoimmune disorder where the ingestion of gluten leads to damage in the small intestine. It is not an allergy caused by gluten.

Celiac disease can be difficult to diagnose because it affects people differently. There are about 300 known symptoms which may occur in the digestive system or other parts of the body. Some people with celiac disease have no symptoms at all, but still test positive on the celiac disease blood test. A few others may have a negative blood test, but have a positive intestinal biopsy. However, all people with celiac disease are at risk for long-term complications, whether or not they display any symptoms.

Celiac disease is hereditary, meaning that it runs in families. People with a first-degree relative with celiac disease (parent, child, and sibling) have a 1 in 10 risk of developing celiac disease. It can develop at any age after people start eating foods or medicines that contain gluten. Left untreated, celiac disease can lead to additional serious health problems.

 

Request for Free Sample Report: https://www.delveinsight.com/sample-request/celiac-disease-cd-market

 

Key Companies Covered:

  • ImmunoGenX
  • Innovate Biopharmaceuticals, Inc.
  • Cour Pharmaceutical Development Company/Takeda
  • And Many Others

 

Drugs Covered:

  • Latiglutenase(IMGX003)
  • INN-202
  • CNP-101
  • And Many Others

 

Request for Free Sample Report: https://www.delveinsight.com/sample-request/celiac-disease-cd-market

 

Table of contents

1. Key Insights

2. Executive Summary of Celiac Disease (CD)

3. Competitive Intelligence Analysis for Celiac Disease (CD)

4. Celiac Disease (CD) : Market Overview at a Glance

5. Celiac Disease (CD) : Disease Background and Overview

6. Patient Journey

7. Celiac Disease (CD) Epidemiology and Patient Population

8. Treatment Algorithm, Current Treatment, and Medical Practices

9. Unmet Needs

10. Key Endpoints of Celiac Disease (CD) Treatment

11. Marketed Products

12. Emerging Therapies

13. Celiac Disease (CD) : Seven Major Market Analysis

14. Attribute analysis

15. 7MM: Market Outlook

16. Access and Reimbursement Overview of Celiac (CD)

17. KOL Views

18. Market Drivers

19. Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

23. About DelveInsight

  

About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.

 

Related Reports:

Celiac Disease – Epidemiology Forecast to 2030

DelveInsight’s ‘Celiac Disease – Epidemiology Forecast to 2030‘ report delivers an in-depth understanding of the disease, historical and forecasted Celiac Disease epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

 

Celiac Disease – Pipeline Insights, 2020

Celiac Disease Pipeline Insight, 2020” report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Celiac Disease market.

 

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/

  Categories: